CDC researchers examine HIV-related stigma among US healthcare providers

October 09, 2018

New Rochelle, NY, October 5, 2018--A Systemic Review from the U.S. Centers for Disease Control and Prevention analyzed studies of HIV-related stigma among healthcare provider and identified three main themes: attitudes, beliefs, and behaviors; quality of patient care; and education and training. The CDC researchers found that factors associated with HIV-related stigma varied by gender, race, category of provider, and type of clinical setting, according to the study results reported in AIDS Patient Care and STDs, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The full-text article is available free on the AIDS Patient Care and STDs website through November 5, 2018 at https://www.liebertpub.com/doi/full/10.1089/apc.2018.0114.

In the article entitled "HIV-Related Stigma by Healthcare Providers in the United States: A Systematic Reviewv," coauthors Angelica Geter, Adrienne Herron, and Madeline Sutton, Centers for Disease Control and Prevention, Atlanta, GA, examined HIV-related stigma by healthcare providers for the purposes of applying their findings to the development of stigma-reduction interventions for healthcare providers in the U.S.

Among their findings, the researchers reported that stigma can be manifested through inadvertent behaviors and beliefs, such as homophobia, transphobia, racism, and negative views of people who inject drugs. This can create a barrier to HIV prevention, treatment, and care, whereas less stigmatizing attitudes by providers can help reduce social and structural barriers to HIV care across the care continuum. More overt HIV-related stigma may manifest as providers who take extreme precautionary measures during routine examinations, use of stigmatizing language, and even denial of necessary services or treatment.

"Most prior studies have focused on the importance of HIV stigma related to family, friends, and personal communities, and how it may prevent an individual from getting tested, seeking treatment, or continuing in HIV care. This study focuses on stigmatizing factors among health care providers themselves," says Editor-in-Chief Jeffrey Laurence, MD, Professor of Medicine, Weill Cornell Medical College, New York, NY.
-end-
About the Journal

AIDS Patient Care and STDs is the leading peer-reviewed journal dedicated to diagnostics and therapeutics for providing optimal care for HIV/AIDS patients. Published monthly online with open access options and in print and online, the Journal spans the full spectrum of adult and pediatric HIV disease, diagnosis, treatment, prevention, and education, enabling clinicians to keep pace with the latest developments in this evolving field. Complete tables of content and a sample issue may be viewed on the AIDS Patient Care and STDs website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including AIDS Research and Human Retroviruses, LGBT Health, Transgender Health, Viral Immunology, and Journal of Palliative Medicine. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals and books is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc./Genetic Engineering News

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.